Literature DB >> 9061657

Epidemiology and socioeconomic impact of skin disease in lupus erythematosus.

B Tebbe1, C E Orfanos.   

Abstract

The prevalence rates of systemic lupus erythematosus (SLE) may vary within 17-48/100,000 population worldwide. Although population-based epidemiological studies are still missing, the cutaneous variants of lupus erythematosus (LE) are 2-3 times more frequent than SLE itself. The most common age of onset is 20-40 y. Overall, cutaneous LE is regarded as a variant with less severe course and better prognosis. However, CDLE and SCLE last for many years and may lead, like SLE, to severe disability for work and limited life quality; also, a small proportion of patients with cutaneous LE develops SLE during the course of their disease. This implies considerable amount of medical management and costs for the community. Early recognition of cutaneous LE patients at risk to develop SLE and preventive measures against disease triggering factors are important tasks for physicians attending with cutaneous LE patients. It seems that signs of nephropathy, elevated ANA-titers and arthralgias may serve as prognostic predictors for transition into SLE. Characteristic features of cutaneous LE are photosensitivity and female predominance. UV light is a major environmental triggering factor in cutaneous LE. Skin lesions may be induced or preexistent lesions may exacerbate due to UV light in up to 80-90% of all patients. Therefore, socioeconomic counseling of the young patients, for example choice of occupation and sun protection, are essentials in compliant patients. Also, since females are 3-6 times more frequently affected than males, the possibility of hormonal influences including pregnancy and estrogen-containing drugs should be discussed. Risk considerations for females wishing to become pregnant are required, and avoidance of estrogen-containing contraceptives should be recommended.

Entities:  

Mesh:

Year:  1997        PMID: 9061657     DOI: 10.1177/096120339700600204

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  39 in total

1.  A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.

Authors:  A G de Tiedra; J Mercadal; X Badía; J M Mascaró; R Lozano
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

2.  Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.

Authors:  Sudumpai Jarukitsopa; Deana D Hoganson; Cynthia S Crowson; Olayemi Sokumbi; Mark D Davis; Clement J Michet; Eric L Matteson; Hilal Maradit Kremers; Vaidehi R Chowdhary
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

3.  [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

4.  [Skin manifestations in lupus erythematosus: clinical aspects and therapy].

Authors:  A Kuhn; V Ruland; G Bonsmann
Journal:  Z Rheumatol       Date:  2011-04       Impact factor: 1.372

5.  The impact of skin damage due to cutaneous lupus on quality of life.

Authors:  S M Verma; J Okawa; K J Propert; V P Werth
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302

6.  Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.

Authors:  F Furukawa; T Itoh; H Wakita; H Yagi; Y Tokura; D A Norris; M Takigawa
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 7.  Cutaneous Lupus Erythematosus: Progress and Challenges.

Authors:  Amy J Petty; Lauren Floyd; Christopher Henderson; Matilda W Nicholas
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.806

8.  Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.

Authors:  Siamak Moghadam-Kia; Katherine Chilek; Elizabeth Gaines; Melissa Costner; Mathew E Rose; Joyce Okawa; Victoria P Werth
Journal:  Arch Dermatol       Date:  2009-03

9.  Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study.

Authors:  Olayemi Durosaro; Mark D P Davis; Kurtis B Reed; Audrey L Rohlinger
Journal:  Arch Dermatol       Date:  2009-03

Review 10.  Cutaneous lupus erythematosus: diagnosis and treatment.

Authors:  L G Okon; V P Werth
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.